Posted: MAR 27, 2008

CSMG Technologies Live Tissue Connect Subsidiary Now Has In-House Disposable Instrumentation Design Capability

Corpus Christi, TX, March 27, 2008 -- CSMG Technologies, Inc., (OTCBB: CTGI - News), a technology management company, announced that its Live Tissue Connect ("LTC") technology subsidiary now has in-house disposable instrumentation capability.

Don Robbins, President and CEO of CSMG Technologies, said, "Over the past 15 months, LTC has utilized the outstanding design and engineering services of VIR Engineering located in Santa Barbara, California. With over 23 years in business, VIR Engineering has decided to close its doors. To enhance its in-house engineering capabilities, LTC has hired VIR's experienced engineering staff. This is the same engineering team that designed and developed LTC's disposable bi-polar instruments."

Frank D'Amelio, President of CSMG Technologies LTC subsidiary commented, "LTC purchased the majority of VIR's laboratory, testing and assembly equipment, tools and fixtures. This equipment will be supplemental to LTC's new R&D laboratory in Santa Barbara, CA."

About Live Tissue Connect

LTC's surgical tissue bonding / welding device is a patented platform technology that bonds and reconnects human soft tissue through fusion, in contrast with conventional wound closing devices such as sutures, staples, sealant, or glues. LTC currently holds a total of approximately 44 patents in the U.S., Australia, Canada, European Union, Ukraine and other countries.

For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.csmgtechinternational.com.

Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to: www.csmgtechinternational.com/contact_information.html and fill-in information.

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

CONTACT:

ROI Group Associates, Inc.
Michael Dodge, 212-495-0744
mdodge@roiny.com
or
CSMG Technologies, Inc.
Donald S. Robbins, 361-887-754
President and CEO
or
K. Bruce Jones, 770-955-0409